• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    How Elevance Health is Evolving the Healthcare Consumer Experience Through Improved Personalization and Higher Touch Service

    11/24/25 10:00:00 AM ET
    $ELV
    Medical Specialities
    Health Care
    Get the next $ELV alert in real time by email

    Elevance Health is making healthcare more intuitive and personalized using technology to simplify access and build trust.

    Elevance Health's affiliated health plans are building loyalty through connection and ongoing support.

    Digital tools address member pain points by providing clear, accurate, and personalized information.

    Saurabh Tandon, Elevance Health's chief experience officer, shared his thoughts on what healthcare has learned from consumer-focused industries, such as streaming services; how to foster consumer loyalty; and what the healthcare experience of the future might look like:

    Is it possible for healthcare or health insurance experiences to become more like using streaming services?

    Actually, the healthcare experience should be even more personalized than a streaming experience. Why? Because healthcare is that much more personal and individual than entertainment. It's hard to gain consumers' trust, so we have to earn it by making the essential elements of healthcare as smooth as possible. While we must know more about consumers - their needs, their lifestyle and their habits - they have to be able to trust us with that information.

    One way we build trust is to be there for consumers when it's convenient for them rather than limiting our assistance to specific office hours. We can make it even easier and more convenient for people to reach us. They can begin a mobile chat session and come back to it minutes, hours, or days later. We work to make common requests, such as finding a care provider in the network, understanding plan benefits, managing claims, handling billing, and dealing with prescriptions, much smoother and simpler.

    It's not enough to personalize healthcare in the same vein as online shopping; we have to be even better. Technology allows us to make this a reality, yet we know we have a great responsibility to do this appropriately and in a way that keeps everyone's data safe.

    How do you foster consumer loyalty in healthcare benefits? How has the company's role begun to change?

    Building consumer loyalty in the realm of healthcare involves a shift in mindset. For decades, our business existed to perform very administrative functions. As we have transformed from that traditional health insurance company to a lifetime trusted health partner, we support consumers in their healthcare journey. This means that beyond providing health insurance benefits, we have introduced programs that complement the excellent work of our care provider partners and simplify the healthcare experience overall. For example, our affiliated health plan care managers help members with everything from finding specialists to helping with housing to making sure they get a regular friendly phone call.

    Concierge care, a program featuring an app that tracks symptoms and contains educational content supplemented by the expertise of a care manager, helps members manage serious illnesses any time of day. It's available for people with various conditions, including Crohn's disease, cancer, behavioral health conditions, and Type 2 diabetes.

    What does the healthcare experience of the future look like? How is it different from today?

    Today's healthcare experience means navigating many different systems – from finding care to paying for it -- with very little visibility into what's the best next step. It's going to get a lot better very quickly, though.

    Legacy healthcare technology was built in silos, and the same steps created to protect privacy and data became stumbling blocks when it came to serving consumers better. Just a short time ago, when people called us for assistance with a claim, we went through many steps with them to verify their identity, confirm their benefits, and articulate the reason for the call. This takes away precious time from addressing their concern. Now, modern technology, specifically artificial intelligence, allows us to go through the same steps instantaneously. We already know why someone has reached out and we should know if they have called us previously so we can be more proactive and personal in solving that problem. This kind of service has only become possible in the last few years because of the power of data and new technology.

    The healthcare experience of the future may look like our ‘My Health Advocate' model (currently in use in our affiliated Medicare plans), in which our care managers (advocates) can resolve issues and get additional help to members when needed. Once an advocate helps a member, future contacts – calls, texts, emails – from that member are managed by the same advocate. This act of matching a member with an advocate also allows us to get to know that member better, which helps us personalize our efforts to support their health in the future.

    Our vision for the future of healthcare involves being there for consumers even before problems start, solving issues quickly, and building long-lasting relationships with them. It's about treating each person as a unique individual.

    Consumers have understandably high expectations for their healthcare experience. We know that in order to fulfill our purpose to improve the health of humanity, we must regularly meet and exceed those expectations.

    About Elevance Health

    Elevance Health is a lifetime, trusted health partner whose purpose is to improve the health of humanity. The company supports consumers, families, and communities across the entire healthcare journey – connecting them to the care, support, and resources they need to lead better lives. Elevance Health's companies serve over 109 million consumers through a diverse portfolio of industry-leading medical, pharmacy, behavioral, clinical, home health, and complex care solutions. For more information, please visit www.elevancehealth.com or follow us @ElevanceHealth on X and Elevance Health on LinkedIn.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20251124462813/en/

    MEDIA CONTACT: Kate Marx, Elevance Health, [email protected]

    Get the next $ELV alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ELV

    DatePrice TargetRatingAnalyst
    10/14/2025Neutral
    Goldman
    7/21/2025Buy → Hold
    Argus
    7/18/2025$310.00Outperform → Market Perform
    Leerink Partners
    4/15/2025$529.00Outperform → Neutral
    Robert W. Baird
    3/17/2025$450.00Hold → Buy
    Argus
    1/22/2025$520.00 → $440.00Overweight → Equal-Weight
    Stephens
    10/18/2024Buy → Hold
    Argus
    7/18/2024$646.00 → $530.00Buy → Neutral
    BofA Securities
    More analyst ratings

    $ELV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: New insider Craig Ryan R claimed ownership of 3,341 shares (SEC Form 3)

    3/A - Elevance Health, Inc. (0001156039) (Issuer)

    11/21/25 4:17:27 PM ET
    $ELV
    Medical Specialities
    Health Care

    EVP & CFO Kaye Mark covered exercise/tax liability with 2,895 shares, decreasing direct ownership by 15% to 16,082 units (SEC Form 4)

    4 - Elevance Health, Inc. (0001156039) (Issuer)

    10/3/25 4:17:15 PM ET
    $ELV
    Medical Specialities
    Health Care

    EVP & Chief Legal Officer Wessling Erin M covered exercise/tax liability with 152 shares, decreasing direct ownership by 3% to 5,020 units (SEC Form 4)

    4 - Elevance Health, Inc. (0001156039) (Issuer)

    9/5/25 4:21:42 PM ET
    $ELV
    Medical Specialities
    Health Care

    $ELV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    How Elevance Health is Evolving the Healthcare Consumer Experience Through Improved Personalization and Higher Touch Service

    Elevance Health is making healthcare more intuitive and personalized using technology to simplify access and build trust. Elevance Health's affiliated health plans are building loyalty through connection and ongoing support. Digital tools address member pain points by providing clear, accurate, and personalized information. Saurabh Tandon, Elevance Health's chief experience officer, shared his thoughts on what healthcare has learned from consumer-focused industries, such as streaming services; how to foster consumer loyalty; and what the healthcare experience of the future might look like: Is it possible for healthcare or health insurance experiences to become more like using stream

    11/24/25 10:00:00 AM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health Reports Third Quarter 2025 Results

    Executing with discipline to improve affordability and elevate the member experience 3Q 2025 operating revenue of $50.1 billion, up 12.0% from 3Q 2024 3Q 2025 diluted EPS1 of $5.32; adjusted diluted EPS2 of $6.03 Reaffirm FY 2025 benefit expense ratio and adjusted diluted EPS guidance of approximately 90.0% and approximately $30.00, respectively Returned $3.3 billion of capital to shareholders year-to-date Elevance Health, Inc. (NYSE:ELV) reported third quarter 2025 results. "Our third quarter results were in line with expectations and reflect disciplined execution across Elevance Health. In a dynamic healthcare environment, we're focused on advancing affordability and ele

    10/21/25 6:00:00 AM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health to Hold Conference Call and Webcast to Discuss Third Quarter 2025 Results on October 21

    Elevance Health (NYSE: ELV) will release third quarter 2025 financial results on October 21, 2025, at 6:00 a.m. Eastern Daylight Time ("EDT"). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 - Access Code - 3972058 (Domestic) 312-470-0178 - Access Code - 3972058 (International) 800-391-9853 - No Access Code (Domestic Replay) 203-369-3269 - No Access Code (International Replay) The replay will be available from 11:30 a.m. EDT on October 21, 2025, until the end of the day on November 21, 2025. Th

    9/29/25 4:30:00 PM ET
    $ELV
    Medical Specialities
    Health Care

    $ELV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goldman initiated coverage on Elevance Health

    Goldman initiated coverage of Elevance Health with a rating of Neutral

    10/14/25 8:49:08 AM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health downgraded by Argus

    Argus downgraded Elevance Health from Buy to Hold

    7/21/25 8:26:59 AM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health downgraded by Leerink Partners with a new price target

    Leerink Partners downgraded Elevance Health from Outperform to Market Perform and set a new price target of $310.00

    7/18/25 8:10:27 AM ET
    $ELV
    Medical Specialities
    Health Care

    $ELV
    SEC Filings

    View All

    Elevance Health Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - Elevance Health, Inc. (0001156039) (Filer)

    11/10/25 5:03:08 PM ET
    $ELV
    Medical Specialities
    Health Care

    SEC Form 10-Q filed by Elevance Health Inc.

    10-Q - Elevance Health, Inc. (0001156039) (Filer)

    10/21/25 11:11:08 AM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition

    8-K - Elevance Health, Inc. (0001156039) (Filer)

    10/21/25 6:01:35 AM ET
    $ELV
    Medical Specialities
    Health Care

    $ELV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Devore Susan D. bought $374,580 worth of shares (1,200 units at $312.15), increasing direct ownership by 52% to 3,502 units (SEC Form 4)

    4 - Elevance Health, Inc. (0001156039) (Issuer)

    8/21/25 4:20:38 PM ET
    $ELV
    Medical Specialities
    Health Care

    President and CEO Boudreaux Gail bought $2,438,951 worth of shares (8,500 units at $286.94), increasing direct ownership by 6% to 151,020 units (SEC Form 4)

    4 - Elevance Health, Inc. (0001156039) (Issuer)

    7/18/25 1:42:51 PM ET
    $ELV
    Medical Specialities
    Health Care

    $ELV
    Financials

    Live finance-specific insights

    View All

    Elevance Health Reports Third Quarter 2025 Results

    Executing with discipline to improve affordability and elevate the member experience 3Q 2025 operating revenue of $50.1 billion, up 12.0% from 3Q 2024 3Q 2025 diluted EPS1 of $5.32; adjusted diluted EPS2 of $6.03 Reaffirm FY 2025 benefit expense ratio and adjusted diluted EPS guidance of approximately 90.0% and approximately $30.00, respectively Returned $3.3 billion of capital to shareholders year-to-date Elevance Health, Inc. (NYSE:ELV) reported third quarter 2025 results. "Our third quarter results were in line with expectations and reflect disciplined execution across Elevance Health. In a dynamic healthcare environment, we're focused on advancing affordability and ele

    10/21/25 6:00:00 AM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health to Hold Conference Call and Webcast to Discuss Third Quarter 2025 Results on October 21

    Elevance Health (NYSE: ELV) will release third quarter 2025 financial results on October 21, 2025, at 6:00 a.m. Eastern Daylight Time ("EDT"). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 - Access Code - 3972058 (Domestic) 312-470-0178 - Access Code - 3972058 (International) 800-391-9853 - No Access Code (Domestic Replay) 203-369-3269 - No Access Code (International Replay) The replay will be available from 11:30 a.m. EDT on October 21, 2025, until the end of the day on November 21, 2025. Th

    9/29/25 4:30:00 PM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health Reports Second Quarter 2025 Results

    2Q 2025 operating revenue of $49.4 billion, up 14.3% from 2Q 2024 2Q 2025 diluted EPS1 of $7.72; adjusted diluted EPS2 of $8.84 Revising FY 2025 adjusted diluted EPS guidance to approximately $30.00 Returned $2.0 billion of capital to shareholders year-to-date Elevance Health, Inc. (NYSE:ELV) reported second quarter 2025 results. "In the second quarter, Elevance Health made meaningful progress in delivering an experience that is simple and personal to those we serve, while advancing our efforts to enhance efficiency across the healthcare system. We are updating our outlook to reflect elevated medical cost trends in ACA and slower rate alignment in Medicaid. While the exter

    7/17/25 6:00:00 AM ET
    $ELV
    Medical Specialities
    Health Care

    $ELV
    Leadership Updates

    Live Leadership Updates

    View All

    Elevance Health Appoints Nathan Rich Vice President, Investor Relations

    Elevance Health (NYSE:ELV) announced today the appointment of Nathan Rich as Vice President, Investor Relations, effective November 11, 2024. In this role, Mr. Rich will lead Elevance Health's investor relations efforts, providing strategic leadership to support the company's growth initiatives and strengthen relationships within the investment community. He will also serve as a member of the company's executive leadership team and will report directly to Mark Kaye, Executive Vice President and Chief Financial Officer. Mr. Rich succeeds Stephen Tanal, who now serves as Chief Financial Officer for Elevance Health's Government Health Benefits business. "Nate brings nearly two decades of expe

    11/4/24 9:00:00 AM ET
    $ELV
    Medical Specialities
    Health Care

    Former Deputy Commissioner of New York State Department of Health Joins Sheppard Mullin

    Nationally Recognized Healthcare Policy Leader Adam Herbst Strengthens the Firm's Regulatory Capabilities for Clients Across the Post-Acute, Aging and Long-Term Care Sectors Sheppard, Mullin, Richter & Hampton LLP is pleased to announce that Adam S. Herbst has joined the firm as a healthcare partner in New York. Most recently, Herbst served as the New York State Department of Health's Deputy Commissioner for Aging and Long Term Care. He is the ninth healthcare partner to join the firm in 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241030758975/en/Adam Herbst (Photo: Business Wire) In joining Sheppard Mullin's industry-l

    10/30/24 12:55:00 PM ET
    $ELV
    Medical Specialities
    Health Care

    Performant Financial Corporation Announces the Appointment of Dr. Shantanu Agrawal to Its Board of Directors

    Performant Financial Corporation (NASDAQ:PFMT) (Performant), primarily operating as Performant Healthcare Solutions, a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, is proud to announce the appointment of Dr. Shantanu Agrawal, M.D. to its Board of Directors. Dr. Agrawal brings a wealth of expertise and experience in healthcare policy and payment integrity. As Chief Health Officer at Elevance Health (NYSE:ELV), Dr. Agrawal oversees the whole health strategy, including medical policy and clinical quality, as well as the community health strategy and Elevance Health Foundation. Prior to Elevance Health, Dr. Agrawal held numerous execut

    3/6/24 4:30:00 PM ET
    $ELV
    $PFMT
    Medical Specialities
    Health Care
    Other Consumer Services
    Consumer Discretionary

    $ELV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Elevance Health Inc.

    SC 13G/A - Elevance Health, Inc. (0001156039) (Subject)

    11/14/24 1:22:35 PM ET
    $ELV
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Elevance Health Inc.

    SC 13G - Elevance Health, Inc. (0001156039) (Subject)

    2/14/24 10:02:59 AM ET
    $ELV
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Elevance Health Inc.

    SC 13G - Elevance Health, Inc. (0001156039) (Subject)

    2/14/23 12:37:59 PM ET
    $ELV
    Medical Specialities
    Health Care